From the Desk of Steve Strazza @Sstrazza

The biotech market has a great divide between the haves and have-nots. Some stocks have experienced tremendous markup phases, while others can't seem to get out of the doghouse.

Today, we're covering a biotech stock that has rallied nearly 200% this year. 

Despite this rally, the short sellers have continued to add to their positions and are close to carrying their largest short position ever.

With the stock coiling at a shelf of former highs from last summer, we're betting the short sellers are on the verge of unwinding their positions and sparking a short squeeze.

These are the registration details for our Live Monthly Candlestick Strategy Session for Premium Members of All Star Charts.

This month’s Video Conference Call will be held on Wednesday September 4th @ 6PM ET. As always, if you cannot make the call live, the video and slides will be archived and published here along with every other live call since 2015.

Here are the details for Wednesday evening:

From the Desk of Steve Strazza @Sstrazza.

Welcome back to Under the Hood, where we'll cover all the action for the two weeks ended August 30, 2024. This report is published bi-weekly, in rotation with The Minor Leaguers.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

We use a variety of sources to generate the list of most popular names.

There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.

This is the weekly post that aggregates all the charts we put together throughout the week and organizes them all into one, easy to flip through deck.

The current market environment is creating a unique opportunity for bonds. 

With the charts signaling strong potential for gains into year-end, now is the moment to take action and add some bond exposure to your portfolio. 

With some big reversals underway, the timing couldn’t be better to capitalize on these new trends. 

Not only are we seeing a growing list of base breakouts for treasuries, corporate bonds, and bond ETFs, but the intermarket landscape is turning increasingly favorable for fixed income in general.

Let’s jump in and discuss why we’re buying bonds here and how we want to express this thesis.

The fed is giving us a clear indication these days that we’ve seen the peak in interest rates for now. The odds of a rate cut at the September meeting in a few weeks are at 67.5%. 

If you're like me, you probably spend too much money on coffee every morning.

And that's not likely to change... but that's okay!

We can profit from an upside move in the commodity and hedge our exposure.

We've had tremendous success trading Cocoa futures in the last several years. 

We're also close to buying Cotton futures as they look to trap the bears below a key polarity zone.

There's a trend here: soft commodities keep rewarding us for owning them.

We think Coffee is next.

From the Desk of Steve Strazza @Sstrazza

Welcome to The Junior International Hall of Famers.

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US-listed international stocks, or ADRs.

This scan is composed of the next 100 largest stocks by market cap, those that come after the top 100 and are thus covered by the International Hall of Famers universe.

Many of these names will someday graduate and join our original International Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

Let’s dive right in and check out what these future big boys are up to.

This is our Junior International Hall of Famers list:

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

In this scan, we look to identify the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

All eyes on Technology today, with $NVDA reporting earnings later this afternoon.

But I'd like to add some different perspective than what you might here on twitter or perhaps on these basic cable networks that no one watches anymore.

There's a reason people keep coming to us for answers.

First of all, let's keep in mind where Technology even is relative to where it's been.

This underperformance we've seen from Large-cap Tech started as soon as it hit the March 2000 highs relative to the S&P500.

It took Technology over 24 years just to get back to where it was at the peak of the dot com bubble.

And that's where we sit today (they won't show you this chart on basic cable):

The fact that Intel is still in the Dow Jones Industrial Average is a joke.

Intel became one of the first 2 companies that trade on the Nasdaq to be included in the Dow. That was way back in 1999 (Microsoft being the 2nd one).

But that was 25 years ago.

Times have changed.

And yet, despite the criminal underperformance from Intel since then, the Dow Jones Industrial Average closed yesterday at another NEW All-time High: